Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04621461 · ClinicalTrials.gov registry record · Phase 4
Placebo Controlled Trial to Evaluate Zinc for the Treatment of COVID-19 in the Outpatient Setting
A Phase 4 study of Corona Virus Infection, sponsored by St. Francis Hospital, New York.
- Completed
- Registry status
- Phase 4
- Development phase
- 3
- Enrollment target
- 1
- Study location
NCT04621461 is a Phase 4 study of Corona Virus Infection that has completed, run by St. Francis Hospital, New York. The registered enrollment target is 3 participants, below the 883-participant average among 15 other Corona Virus Infection trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state.
The verdict
NCT04621461, a Phase 4 study of Corona Virus Infection, has completed, sponsored by St. Francis Hospital, New York.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 3 participants
- Enrollment target
- 1
- Study location
Study Summary
This is a randomized, double-blind, placebo-controlled trial to assess the efficacy of zinc in a higher risk COVID-19 positive outpatient population.
Conditions Studied
Interventions
- DRUG Placebo
- DIETARY_SUPPLEMENT Zinc Sulfate 220 MG
Study Locations (1)
New York
- St. Francis Hospital - The Heart Center - Roslyn
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3 participants |
| Start Date | 2020-12-20 |
| Est. Completion | 2021-02-08 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04621461
The ClinicalTrials.gov registry entry for NCT04621461 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 3 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 883-participant average among 15 other Corona Virus Infection trials with a reported enrollment target (100% lower). The listed sponsor is St. Francis Hospital, New York, which has 5 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Corona Virus Infection appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.
NCT04621461 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.
Frequently Asked Questions
What is clinical trial NCT04621461 about?
NCT04621461 is a clinical study titled "Placebo Controlled Trial to Evaluate Zinc for the Treatment of COVID-19 in the Outpatient Setting". This is a randomized, double-blind, placebo-controlled trial to assess the efficacy of zinc in a higher risk COVID-19 positive outpatient population.
What is the current status of trial NCT04621461?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 3 participants. The study started on 2020-12-20. Estimated completion is 2021-02-08.
What conditions does trial NCT04621461 study?
This clinical trial studies the following conditions: Corona Virus Infection.
What interventions are being tested in trial NCT04621461?
The interventions under investigation include: Placebo (DRUG), Zinc Sulfate 220 MG (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT04621461?
This trial is sponsored by St. Francis Hospital, New York, which has 5 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04621461 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Corona Virus Infection
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Assessing Safety of Coronavirus Infection (COVID-19) Messenger RNA (mRNA) Vaccine Administration in the Setting of a Previous Adverse Reaction
COMPLETED · Phase 4
-
Understanding Immunity to the Flu Vaccine in COVID-19 Patients
RECRUITING
-
Risk Factors, Clinical Characteristics and Outcomes of Acute Infection With Coronavirus 2019 (COVID-19) In Children
RECRUITING
-
Determinants of SARS (Severe Acute Respiratory Syndrome)-COV2 (COVID-19) Persistence After Convalescence
RECRUITING
-
A Study to Explore the Role of Gut Flora in COVID-19 Infection
RECRUITING
-
KIDney Injury in Times of COVID-19 (KIDCOV)
RECRUITING
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.